维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Eechoute K"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity 显示文摘	van Erp NP Eechoute K van der Veldt AA	2009	J Clin Oncol2009，27，26：	1
2	D r ugtransporters of platinum-based anticancer agents and theirclinical significance 显示文摘	BURGER H LOOS WJ EECHOUTE K e t a l	2011	Drug Resist Updat2011，14，1：	1
3	Drug transporters and imatinib treatment:implications for clinical practice显示文摘	Eechoute K Sparreboom A Burger H	2011	Clin Cancer Res2011，17，3：	1
4	Pharmacoge-netic pathway analysis for determination of sunitinib-induced tox-icity显示文摘	van Erp NP Eechoute K van der Veldt AA	2009	J Clin Oncol2009，27，26：	1
5	Pharmaco- genetic pathway analysis for determination of sunitinib-in-duced toxicity显示文摘	Van Erp NP Eechoute K van der Veldt AA	2009	J Clin 0ncot2009，27，26：	1
6	Genetic polymorphisms associated with a prolonged progression-free sur- vival in patients with metastatic renal cell cancer treated with sunitinib显示文摘	van der Veldt AA Eechoute K Gelderblom H	2011	Clin Cancer Res2011，17，3：	1
7	Pharmacogenetic pathway analysis for determination of sunitinib- induced toxicity显示文摘	van Erp NP Eechoute K van der Veldt AA	2009	J Clin Onco]2009，27，：	1
8	Drug transporters of platinum-based anticancer agents and their clinical significance 显示文摘	Burger H Loos WJ Eechoute K etal	2011	Drug Resist Updat2011，14，1：	1
9	Drug trans- porters and imatinib treatment: implications for clinical practice显示文摘	Eechoute K Sparreboom A Burger H	2011	Clin Cancer Res2011，17，3：	1
10	Environmental and genetic factors affecting transport of imatinib by OATP1A2显示文摘	EECHOUTE K FRANKE R M LOOS W J	2011	Clin Pharmacol Ther2011，89，6：	1
11	Geneticpolymorphisms associated with a prolonged progression-free survivalin patientswith metastatic renal cell cancer treated with sunitinib显示文摘	van der Veldt AA Eechoute K Gelderblom H	2011	Clin Cancer Res2011，17，3：	1
12	Genetic polymorphisms associated with a prolonged progression-free survival in patients with metastatic renal cell cancer treated with sunitinib显示文摘	yan der Veldt AA Eechoute K Gelderblom H	2011	Clin Cancer Res2011，17，3：	1
13	Drug transportersand imatinib treatment :implications for clinical practice显示文摘	Eechoute K Sparreboom A Burger H	2011	ClinCancer Res2011，17，3：	1
14	Polymorphisms in endothelial nitric oxide synthase(e NOS)and vascular endothelial growth factor(VEGF)predict sunitinib-induced hypertension显示文摘	Eechoute K van der Veldt AA Oosting S	2012	Clin Pharmacol Ther2012，92，4：	1
15	Environmental and genetic factors affecting transport of imatinib by OATP1A2 显示文摘	EECHOUTE K FRANKE RM LOOS WJ	2011	Clin Pharmacol Ther2011，89，6：	1
16	Genetic polymorphisms associated with a prolonged progression-free survival in patients with metastatic renal cell cancer treated with sunitinib显示文摘	van der Veldt AA Eechoute K Gelderblom H		0，，03：	1
17	Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity显示文摘	van Erp NP Eechoute K van der Veldt AA	2009	J Clin Oncol2009，27，26：	1
18	Pharmaco-genetic pathway analysis for determination of sunitinib- induced toxicity 显示文摘	van Erp NP Eechoute K van der Veldt AA	2009	J Clin Oncol2009，27，：	1
19	Pharma-cogenetic pathway analysis for determination of sunitinib-inducedtoxicity 显示文摘	Van Erp NP Eechoute K van der Veldt AA	2009	J Clin Oncol2009，27，44：	1
20	Drug trans- porters and imatinib treatment: implications for clinical practice显示文摘	Eechoute K Sparreboom A Burger H	2011	Clin Cancer Res2011，17，3：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示